Matching patients to clinical trials is very important to test new treatments on the right people and to give patients a chance to try new therapies. But this process is hard for several reasons:
Artificial intelligence (AI) can study large amounts of data fast and correctly. In the United States, many healthcare groups use AI methods like machine learning (ML), natural language processing (NLP), and graph analytics to overcome old problems.
Groups like Oak Ridge National Laboratory, through its Health Data Sciences Institute, created AI tools that use natural language processing to find useful facts in unstructured clinical notes. Their “SmartClinicalTrials” system uses graph analytics to connect EHRs, medical knowledge, and public data into one big graph. This helps computers keep analyzing and find patients who fit trial rules more easily.
Ioana Danciu of ORNL said using AI for unstructured data is very important because it makes trial matching possible where it was hard before. Georgia Tourassi, also from ORNL, talked about how working together with government health groups helps speed up progress by sharing data and knowledge.
AI algorithms help find eligible patients faster and more accurately. AI looks at big data like patient information, genes, medical history, and current treatments to guess who fits certain trials. This is especially useful in cancer care, where gene data and molecular profiles are studied to match patients to new trials.
For example, Tempus works with many medical centers and oncologists in the U.S. It uses AI to study patient data and find trial matches. Tempus has helped find over 30,000 patients for trial enrollment, which speeds up research and helps patients get treatments that fit their needs.
Finding patients for trials is often a big problem. AI helps healthcare teams in the U.S. by predicting which patients are likely to join and benefit. Tools that combine EHR data with AI let teams reach out to patients using real-time information without extra manual work.
Companies such as Lindus Health use AI platforms that handle recruitment, keep patients in trials, and monitor remotely. This helps trial diversity and makes trials easier to access. AI also helps patients follow their medicine routines by sending reminders and coaching, which supports better trial results.
Generative AI (GenAI) is a newer AI tool that helps make trial plans faster. It can create draft protocols in minutes instead of days. By looking at new data all the time, it can help change trials while they are running for better results.
Wing Lon Ng from IQVIA says AI should be combined with human decisions to keep ethics and patient safety. This “human-in-the-loop” idea helps choose good trial sites and recruitment plans that follow rules and adjust as needed.
Besides matching patients, AI helps with everyday work in healthcare. AI-powered workflow automation reduces paperwork and helps care teams work better.
NLP tools take patient eligibility information from EHRs automatically. This saves time and lowers the chance of mistakes, so eligible patients get found on time.
AI can set up appointments and reminders for trial visits automatically. Chatbots and virtual helpers keep patients involved by sending reminders, answering common questions, and sharing trial details without needing constant staff help.
AI tools work with electronic health records so clinical and IT staff can use trial data within their daily work. This reduces separate data systems and helps teams work better together.
AI tracks how data is used to meet rules like HIPAA and GDPR. It can hide patient identities during analysis and keep records of data use, helping organizations follow laws and protect privacy while using full datasets for matching.
AI-based clinical trial matching helps U.S. patients by giving faster access to new treatments and personalized medicine. Finding the right patients quickly means more people can join trials with treatments not found in normal care.
Trials get more patients and more varied groups, making the results better for everyone. AI can use gene, medical, and behavior data to sort patients well, supporting precise treatment plans.
This is very helpful in cancer care, where gene testing is key. Tempus works with top pharmaceutical companies in cancer research, showing how AI helps develop drugs faster and makes trials work better.
Using AI in trials also brings challenges with data quality, ethics, openness, and training.
Medical practice managers in the U.S. play a big role in using AI for trial matching. They must balance new tech with current workflows, rules, and patient privacy.
AI tools in clinical trial matching are an important step for healthcare in the United States. From pulling detailed patient data to fitting into daily work, AI helps find patients faster, speeds up research, and can lead to better patient health. For medical managers, owners, and IT staff, understanding and adopting AI will be important to support precise medicine and patient care in clinical research.
AI-enabled precision medicine uses artificial intelligence to enhance patient care by accelerating the discovery of new treatment targets, predicting treatment effectiveness, and identifying suitable clinical trials, ultimately allowing for earlier diagnoses of various diseases.
AI can help healthcare providers make more informed treatment decisions by analyzing large volumes of data, identifying care gaps, and providing tailored insights that lead to better patient outcomes.
AI can efficiently handle high call volumes, reducing wait times for patients, streamlining appointment scheduling, and improving overall patient engagement, which enhances the patient experience.
AI assists in clinical trial matching by analyzing patient data and identifying individuals who may qualify for specific trials, increasing the chances of successful enrollment and outcomes.
Tempus partners with over 95% of the top 20 pharmaceutical companies in oncology by providing molecular profiling and data-driven insights to enhance drug development and treatment personalization.
Tempus utilizes multimodal real-world data, including genomic, clinical, and behavioral data, helping to provide comprehensive insights into patient care and treatment options.
AI improves patient care by enabling high-quality testing, efficient trial matching, and deep analysis of research data, all contributing to better patient outcomes.
Olivia is an AI-enabled personal health concierge app designed for patients and caregivers to help them manage, organize, and proactively control their health data.
Tempus launched a collaboration with BioNTech for real-world data usage and received FDA clearance for its AI-based Tempus ECG-AF device to identify patients at risk of atrial fibrillation.
AI accelerates the identification of novel therapeutic targets, enhancing the speed and accuracy of treatment development in precision medicine, which is critical in improving patient outcomes in complex diseases.